Therapeutic Effect of Cell Transplantation and Chondroitinase in Rat Spinal Cord Injury

Overview

Journal Int J Appl Basic Med Res

Specialty General Medicine

Date 2019 Jan 2

PMID 30598908

Citations 4

Authors

Durai Murugan Muniswami

George Tharion

Affiliations

Soon will be listed here.

Abstract

Background: Spinal cord injury (SCI) leads to permanent functional deficits because the central nervous system lacks the ability for spontaneous repair. Cell therapy strategies offered a hope in neurological repair. The clinical use of human embryonic stem cell transplantation is hampered by scientific and ethical controversies. Olfactory ensheathing cells (OECs)/bone marrow mesenchymal stem cell (MSC) is a promising cell source for autologous neurotransplantation devoid of ethical concerns.

Aim: This study aimed to evaluate the combined therapeutic effect of OEC, MSC, and chondroitinase in SCI rat models.

Materials And Methods: Adult female albino Wistar rats were divided into ten groups, = 6 rats in each group and control ( = 11). T10 level laminectomy was done in anesthetized rats to create drop-weight SCI. Both OEC and MSC were transplanted on the 9 day following SCI as a combined therapy with different dosage of 2 × 10, 5 × 10, 10 × 10, and >10 × 10 at a ratio of 1:1 with/without chondroitinase (0.2 U). One group of SCI rats was treated with chondroitinase alone 0.2 U. Dulbecco's Modified Eagle medium was injected in control rats. The outcome of transplantation was assessed using Basso, Beattie, Bresnahan (BBB) scale and motor-evoked potential studies.

Results: All the treated groups showed hindlimb motor recovery in BBB score except control group ( < 0.05). All the three combinations showed better results than OEC + MSC groups in hindlimb motor recovery. In dose-response relationship, 5- and 10-lakh combinations elicited increased functional recovery than 2- and more than 10-lakh combinations. However, chondroitinase alone demonstrated a highest BBB score than any other groups.

Conclusions: Chondroitinase/cell combinations have a therapeutic beneficial effect in SCI.

Citing Articles

Mesenchymal Stem Cells Therapy Led to the Improvement of Spatial Memory in Rats with Alzheimer's disease Through Changing the Expression of LncRNA TUSC7/ miR-449a/ PPARγ and CD36 Genes in the Brain Tissue.

Pezeshki S, Karimi Darabi M, Nazeri Z, Sarkaki A, Rashidi M, Babaahmadi-Rezaei H Int J Mol Cell Med. 2024; 12(2):108-119.

PMID: 38313374 PMC: 10837912. DOI: 10.22088/IJMCM.BUMS.12.2.108.

Regenerative Medicine: Pharmacological Considerations and Clinical Role in Pain Management.

Kaye A, Edinoff A, Rosen Y, Boudreaux M, Kaye A, Sheth M Curr Pain Headache Rep. 2022; 26(10):751-765.

PMID: 36074255 PMC: 9453705. DOI: 10.1007/s11916-022-01078-y.

Reliable cell purification and determination of cell purity: crucial aspects of olfactory ensheathing cell transplantation for spinal cord repair.

Reshamwala R, Shah M, Belt L, Ekberg J, St John J Neural Regen Res. 2020; 15(11):2016-2026.

PMID: 32394949 PMC: 7716040. DOI: 10.4103/1673-5374.282218.

Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates.

Lindsay S, McCanney G, Willison A, Barnett S Nat Rev Neurol. 2020; 16(4):229-240.

PMID: 32099190 DOI: 10.1038/s41582-020-0311-0.

References

Fitch M, Doller C, Combs C, Landreth G, Silver J . Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci. 1999; 19(19):8182-98. PMC: 6783021. View

Gudino-Cabrera G, Nieto-Sampedro M . Schwann-like macroglia in adult rat brain. Glia. 2000; 30(1):49-63. DOI: 10.1002/(sici)1098-1136(200003)30:1<49::aid-glia6>3.0.co;2-m. View

Ramon-Cueto A, Cordero M, Avila J . Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron. 2000; 25(2):425-35. DOI: 10.1016/s0896-6273(00)80905-8. View

Yick L, Wu W, So K, Yip H, Shum D . Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. Neuroreport. 2000; 11(5):1063-7. DOI: 10.1097/00001756-200004070-00032. View

Lakatos A, Franklin R, Barnett S . Olfactory ensheathing cells and Schwann cells differ in their in vitro interactions with astrocytes. Glia. 2000; 32(3):214-25. DOI: 10.1002/1098-1136(200012)32:3<214::aid-glia20>3.0.co;2-7. View

Boruch A, Conners J, Pipitone M, Deadwyler G, Storer P, DeVries G . Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia. 2001; 33(3):225-9. View

Woodhall E, West A, Chuah M . Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res Mol Brain Res. 2001; 88(1-2):203-13. DOI: 10.1016/s0169-328x(01)00044-4. View

Raisman G . Olfactory ensheathing cells - another miracle cure for spinal cord injury?. Nat Rev Neurosci. 2001; 2(5):369-75. DOI: 10.1038/35072576. View

Asher R, Morgenstern D, Moon L, Fawcett J . Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog Brain Res. 2001; 132:611-9. DOI: 10.1016/S0079-6123(01)32106-4. View

10.

Bradbury E, Moon L, Popat R, King V, Bennett G, Patel P . Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 2002; 416(6881):636-40. DOI: 10.1038/416636a. View

11.

Takami T, Oudega M, Bates M, Wood P, Kleitman N, Bunge M . Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci. 2002; 22(15):6670-81. PMC: 6758124. DOI: 20026636. View

12.

Morgenstern D, Asher R, Fawcett J . Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res. 2002; 137:313-32. DOI: 10.1016/s0079-6123(02)37024-9. View

13.

Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J . Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology. 2003; 22(4):275-9. DOI: 10.1046/j.1440-1789.2002.00450.x. View

14.

Li Y, Decherchi P, Raisman G . Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J Neurosci. 2003; 23(3):727-31. PMC: 6741902. View

15.

Plant G, Christensen C, Oudega M, Bunge M . Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma. 2003; 20(1):1-16. DOI: 10.1089/08977150360517146. View

16.

Keyvan-Fouladi N, Raisman G, Li Y . Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci. 2003; 23(28):9428-34. PMC: 6740581. View

17.

Barnett S . Olfactory ensheathing cells: unique glial cell types?. J Neurotrauma. 2004; 21(4):375-82. DOI: 10.1089/089771504323004520. View

18.

Li Y, Carlstedt T, Berthold C, Raisman G . Interaction of transplanted olfactory-ensheathing cells and host astrocytic processes provides a bridge for axons to regenerate across the dorsal root entry zone. Exp Neurol. 2004; 188(2):300-8. DOI: 10.1016/j.expneurol.2004.04.021. View

19.

Lu P, Yang H, Jones L, Filbin M, Tuszynski M . Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci. 2004; 24(28):6402-9. PMC: 6729552. DOI: 10.1523/JNEUROSCI.1492-04.2004. View

20.

Raisman G . Olfactory ensheathing cells and repair of brain and spinal cord injuries. Cloning Stem Cells. 2005; 6(4):364-8. DOI: 10.1089/clo.2004.6.364. View